This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Record Close in Tel Aviv

The Tel Aviv 100 index, which tracks the largest companies on Israel's exchange, crossed the much-anticipated 1000 level for the first time Wednesday, completing a 5.5% climb since the beginning of the year.

Share increases across the board were fueled by a host of bullish corporate and economic news.

Earlier this week, Standard and Poor's raised its outlook on Israel's debt from negative to stable based on "improved economic and fiscal resilience to external shocks." That followed similar upbeat outlooks and credit upgrades by both Fitch and Moody's.

Also adding to a red-hot trading environment was a note by Morgan Stanley, which said it expects 5% GDP growth in Israel in 2007 and an even higher growth rate in 2008. The estimates top the Bank of Israel's previous estimate of a 4.5% expansion this year.

On the corporate front, Teva Pharmaceutical's (TEVA - Get Report) in-line earnings outlook and solid sales guidance for 2007, along with news reports of a possible acquisition of Israel's Retalix (RTLX) by VeriFone (PAY - Get Report), helped the overall bullishness. Retalix surged 7%.

Still, since positive momentum has been dominating the Tel Aviv indices for a while now, analysts and investors keep asking themselves whether it can continue for much longer. The Tel Aviv 100 index rose by more than 50% in the last two years.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
PAY $37.61 0.00%
TEVA $60.70 0.00%
AAPL $132.04 0.00%
FB $80.55 0.00%
GOOG $539.79 0.00%


DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs